World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
49866
World Ranking
9098
National Ranking
4691

Overview

Fred H. Hochberg is affiliated with Massachusetts General Hospital in the United States. Their research primarily focuses on medicine, with notable work in pulmonary and respiratory medicine, neurology, cancer research, molecular biology, and radiology, nuclear medicine, and imaging. The scientist's subfields of study include pulmonary and respiratory medicine, neurology, cancer research, molecular biology, and radiology, nuclear medicine, and imaging.

Their work covers several main topics including:

  • CNS lymphoma diagnosis and treatment
  • Cancer genomics and diagnostics
  • Single-cell and spatial transcriptomics
  • Radiomics and machine learning in medical imaging
  • Lymphoma diagnosis and treatment
  • Chronic lymphocytic leukemia research
  • Lung cancer treatments and mutations

Fred H. Hochberg has contributed to multiple research papers, including:

  • The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring, 2023, Cell Reports Medicine
  • Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial, 2020, The Oncologist
  • Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer, 2020, UNC Libraries
  • Alimta (Pemetrexed) in recurrent or progressive primary central nervous system lymphoma: A Phase I multicenter Clinical Trial (2809), 2020, Neurology

The scientist has published frequently in several venues, with multiple publications in:

  • Cell Reports Medicine
  • The Oncologist
  • UNC Libraries
  • Neurology

Frequent collaborators include Jörg Dietrich, Laura Versmée, Jan Drappatz, April F. Eichler, and Lakshmi Nayak, each appearing as coauthors multiple times.

Best Publications

  • Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Clotilde Théry;Kenneth W. Witwer;Elena Aikawa;Maria Jose Alcaraz

  • Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles.

    Jan Lötvall;Andrew F Hill;Fred H. Hochberg;Edit I Buzás

  • Standardization of sample collection, isolation and analysis methods in extracellular vesicle research

    Kenneth W. Witwer;Edit I. Buzás;Lynne T. Bemis;Adriana Bora

  • Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

    Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger

  • Assumptions in the radiotherapy of glioblastoma

    Fred H. Hochberg;Amy Pruitt

  • Cerebral blood volume maps of gliomas : comparison with tumor grade and histologic findings

    H J Aronen;I E Gazit;D N Louis;B R Buchbinder

  • Intracranial germ-cell tumors: natural history and pathogenesis.

    Mark T. Jennings;Rebecca Gelman;Fred Hochberg

  • Primary central nervous system lymphoma

    Fred H. Hochberg;Douglas C. Miller

  • Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

    Huilin Shao;Jaehoon Chung;Leonora Balaj;Alain Charest

  • Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07

    Tracy Batchelor;Kathryn Carson;Alison O’Neill;Stuart A. Grossman

  • Glial Tumor Grading and Outcome Prediction Using Dynamic Spin-Echo MR Susceptibility Mapping Compared with Conventional Contrast-Enhanced MR: Confounding Effect of Elevated rCBV of Oligodendroglimoas

    Michael H. Lev;Yelda Ozsunar;Yelda Ozsunar;John W. Henson;Amjad A. Rasheed

  • Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma.

    Huilin Shao;Jaehoon Chung;Jaehoon Chung;Kyungheon Lee;Leonora Balaj

  • Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

    Tracy T. Batchelor;Dan G. Duda;Emmanuelle di Tomaso;Marek Ancukiewicz

  • A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

    E. Antonio Chiocca;Khalid M. Abbed;Stephen Tatter;David N. Louis

  • Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.

    Nancy U. Lin;Lisa A. Carey;Minetta C. Liu;Jerry Younger

  • Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma : long-term outcome

    Jon Glass;Michael L. Gruber;Lawrence Cher;Fred H. Hochberg

  • Coding and noncoding landscape of extracellular RNA released by human glioma stem cells

    Zhiyun Wei;Arsen O. Batagov;Sergio Schinelli;Jintu Wang

  • Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

    Keiro Ikeda;Tomotsugu Ichikawa;Hiroaki Wakimoto;Jonathan S. Silver

  • Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.

    Douglas C. Miller;Fred H. Hochberg;Nancy L. Harris;Michael L. Gruber

  • Applying extracellular vesicles based therapeutics in clinical trials

    Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger

Frequent Co-Authors

Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
Bob S. Carter
Bob S. Carter Harvard University
Xandra O. Breakefield
Xandra O. Breakefield Harvard University
David N. Louis
David N. Louis Harvard University
Patrick Y. Wen
Patrick Y. Wen Harvard University
E. Antonio Chiocca
E. Antonio Chiocca Brigham and Women's Hospital
Jay S. Loeffler
Jay S. Loeffler Harvard University
Stuart A. Grossman
Stuart A. Grossman Johns Hopkins University
Bruce R. Rosen
Bruce R. Rosen Harvard University
Michael H. Lev
Michael H. Lev Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA but wish to explore alternative or complementary paths, several online healthcare programs can help launch your career. For those aiming to become registered nurses, finding the easiest rn program to get into is a practical way to start, especially if you want to enter the workforce quickly.

Some prospective nurses may be concerned about standardized test requirements. In this case, choosing a nursing school that does not require teas test can simplify the admissions process.

For those more interested in the administrative side of healthcare, consider pursuing a degree from one of the best healthcare administration degrees available online. These accelerated programs equip you for management roles in hospitals and clinics.

Alternatively, medical billing and coding offers a vital support role in the health sector. Many reputable medical billing and coding online schools that accept financial aid allow you to train remotely, making the path to certification more accessible than ever.

Best Scientists Citing Fred H. Hochberg

Trending Scientists

Recently Published Articles